Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001689575-26-000015

CHIEF EXECUTIVE OFFICER sold 3,678 shares at $86.75 ($319,059)

  • CHIEF EXECUTIVE OFFICER acquired 6,546 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stueland Katherine CHIEF EXECUTIVE OFFICER 2026-03-09 Option exercise +6,546 48,633 D
Stueland Katherine CHIEF EXECUTIVE OFFICER 2026-03-09 Sale −3,678 $86.75 $319,059 44,955 D
Derivatives
Stueland Katherine CHIEF EXECUTIVE OFFICER 2026-03-09 Option exercise · Restricted Stock Unit −6,546 19,640 D
Open-market sales · 3,678 sh · avg $86.75 · $319,059
Loading xslF345X05/form4-03112026_080333.xml…